Data presented in Figure 2 suggest that tumor radiation-sensitization through the inhibition of EGFR signaling could yield a therapeutic gain by increasing the locoregional control rate in patients with EGFR-overexpressing rectal cancer. Here, EGFR is linked to neoplasm.